.png)
Clinically-proven ingredients
No office visit required
Silky, Hydrated, and Even-Toned
Final pricing will vary based on the selected product and subscription plan. Featured items may include compounded medications, which are not approved by the FDA. The FDA does not evaluate the safety or efficacy of compounded drugs.
.png)
Answer a few questions about your symptoms and health history.
A licensed medical provider will determine if treatment is right for you.
If prescribed, your treatment ships discreetly to your door, for free.
Please contact us if you don't see the answer you're looking for
Get StartedE-Tele offers medical weight loss program that's physician lead to help you achieve your weight loss goals
We are here to serve you on your schedule. We deliver Simple, convenient and private solutions to fit your needs. Follow the links to fill out an E-Consult form on your schedule, not ours.
We do not require insurance, our weight loss programs are affordable to make it convenient for you to pay
Semaglutide is a GLP-1 receptor agonist used for managing type 2 diabetes and for weight management. It mimics a hormone that helps regulate blood sugar and appetite.
Tirzepatide is a newer injectable medication that works similarly to semaglutide but with a broader effect. It activates both the GLP-1 and GIP (Gastric Inhibitory Polypeptide) receptors to help control blood sugar and promote weight loss.
Both medications help lower blood sugar by increasing insulin secretion when blood sugar levels are elevated. They also slow gastric emptying, leading to reduced appetite and potential weight loss.
Semaglutide is approved for managing type 2 diabetes and for chronic weight management in adults with obesity or overweight (when combined with diet and exercise).
Tirzepatide is approved for managing type 2 diabetes and is also approved for chronic weight management in adults with obesity or overweight (similar to Semaglutide)..
Yes, it is approved for weight loss in individuals with obesity or overweight with related health issues
Nausea, vomiting, diarrhea, and constipation are common side effects.
It’s injected subcutaneously (under the skin) once a week.
If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.
Yes, studies suggest it is safe for long-term use, but ongoing monitoring is recommended.
If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.
Moderate alcohol consumption is usually fine, but excessive drinking should be avoided
It typically does not cause low blood sugar unless used with other diabetes medications that lower glucose.
Yes, but consult your healthcare provider, especially if you're taking other diabetes medications or blood pressure medications. .
People with a history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should avoid it.
Yes, it improves insulin sensitivity, which may help with insulin resistance.
Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.
Keep it in the refrigerator until use
Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.
No, Semaglutide is not addictive.
Yes, it is approved for weight loss in people with obesity or related conditions.
Side effects include nausea, diarrhea, vomiting, and decreased appetite
E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) partners with independent licensed physician networks, including MDI Medical Group, P.C., to deliver medical services through the E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) infrastructure. E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) does not directly provide medical or pharmacy services. Payment does not guarantee a prescription will be written or dispensed, and you are only charged if a prescription is issued. Medical services are rendered by independent providers. Actual medication form and appearance may differ from what is shown.
Information on this website is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you have health-related questions or concerns, please consult your doctor. This website is an advertisement for services, not for any specific medication. Disclaimer: Saxenda®, Victoza®, Wegovy®, and Ozempic® are trademarks of Novo Nordisk™, while Mounjaro™ is a product of Eli Lilly and Company™. E-Tele is not associated with or endorsed by these companies or their products. We do not supply these medications. Individuals interested in these products should consult with their licensed healthcare provider or pharmacist. Compounded semaglutide is offered in response to the ongoing FDA Drug Shortage. For up to date information on drug shortage statuses,
please visit: https://www.accessdata.fda.gov/scripts/drugshortages/
